BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SETD2, ENSG00000181555, 29072
18 results:

  • 1. Bioinformatics analysis-based screening of circRNA gene with mainstream expression trend in colorectal cancer and construction of a coexpression regulatory network.
    Xu L; Zhang H; Shao Y; Fu Z
    PLoS One; 2023; 18(12):e0295126. PubMed ID: 38064496
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Loss of setd2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathway.
    Ma C; Liu M; Feng W; Rao H; Zhang W; Liu C; Xu Y; Wang Z; Teng Y; Yang X; Ni L; Xu J; Gao WQ; Lu B; Li L
    Clin Transl Med; 2023 Nov; 13(11):e1475. PubMed ID: 37962020
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical and histopathologic characterization of setd2-mutated colorectal cancer.
    Bushara O; Wester JR; Jacobsen D; Sun L; Weinberg S; Gao J; Jennings LJ; Wang L; Lauberth SM; Yue F; Liao J; Yang GY
    Hum Pathol; 2023 Jan; 131():9-16. PubMed ID: 36502925
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. setd2 supports GATA3
    Ding Z; Cai T; Tang J; Sun H; Qi X; Zhang Y; Ji Y; Yuan L; Chang H; Ma Y; Zhou H; Li L; Sheng H; Qiu J
    Nat Commun; 2022 Dec; 13(1):7468. PubMed ID: 36463230
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Deciphering the etiology and role in oncogenic transformation of the CpG island methylator phenotype: a pan-cancer analysis.
    Yates J; Boeva V
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35134107
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. H3K36 trimethylation-mediated biological functions in cancer.
    Xiao C; Fan T; Tian H; Zheng Y; Zhou Z; Li S; Li C; He J
    Clin Epigenetics; 2021 Oct; 13(1):199. PubMed ID: 34715919
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular Characterization of Peritoneal Mesotheliomas.
    Offin M; Yang SR; Egger J; Jayakumaran G; Spencer RS; Lopardo J; Nash GM; Cercek A; Travis WD; Kris MG; Ladanyi M; Sauter JL; Zauderer MG
    J Thorac Oncol; 2022 Mar; 17(3):455-460. PubMed ID: 34648949
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The histone methyltransferase setd2 modulates oxidative stress to attenuate experimental colitis.
    Liu M; Rao H; Liu J; Li X; Feng W; Gui L; Tang H; Xu J; Gao WQ; Li L
    Redox Biol; 2021 Jul; 43():102004. PubMed ID: 34020310
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of Patient Age on Molecular Alterations of Left-Sided colorectal Tumors.
    Puccini A; Lenz HJ; Marshall JL; Arguello D; Raghavan D; Korn WM; Weinberg BA; Poorman K; Heeke AL; Philip PA; Shields AF; Goldberg RM; Salem ME
    Oncologist; 2019 Mar; 24(3):319-326. PubMed ID: 30018131
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Novel insights into transcriptional dysregulation in colorectal cancer.
    Feodorova Y; Tashkova D; Koev I; Todorov A; Kostov G; Simitchiev K; Belovejdov V; Dimov R; Sarafian V
    Neoplasma; 2018 Mar; 65(3):415-424. PubMed ID: 29788743
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Histone methyltransferase setd2 modulates alternative splicing to inhibit intestinal tumorigenesis.
    Yuan H; Li N; Fu D; Ren J; Hui J; Peng J; Liu Y; Qiu T; Jiang M; Pan Q; Han Y; Wang X; Li Q; Qin J
    J Clin Invest; 2017 Sep; 127(9):3375-3391. PubMed ID: 28825595
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G
    Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.
    Chakrabarty S; Varghese VK; Sahu P; Jayaram P; Shivakumar BM; Pai CG; Satyamoorthy K
    Br J Cancer; 2017 Jun; 117(1):136-143. PubMed ID: 28524162
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. colorectal cancer Genetic Heterogeneity Delineated by Multi-Region Sequencing.
    Lu YW; Zhang HF; Liang R; Xie ZR; Luo HY; Zeng YJ; Xu Y; Wang LM; Kong XY; Wang KH
    PLoS One; 2016; 11(3):e0152673. PubMed ID: 27023146
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A Systematic Approach to Defining the microRNA Landscape in Metastasis.
    Mudduluru G; Abba M; Batliner J; Patil N; Scharp M; Lunavat TR; Leupold JH; Oleksiuk O; Juraeva D; Thiele W; Rothley M; Benner A; Ben-Neriah Y; Sleeman J; Allgayer H
    Cancer Res; 2015 Aug; 75(15):3010-9. PubMed ID: 26069251
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Microsatellite instability: an update.
    Yamamoto H; Imai K
    Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Frameshift mutation of a histone methylation-related gene SETD1B and its regional heterogeneity in gastric and colorectal cancers with high microsatellite instability.
    Choi YJ; Oh HR; Choi MR; Gwak M; An CH; Chung YJ; Yoo NJ; Lee SH
    Hum Pathol; 2014 Aug; 45(8):1674-81. PubMed ID: 24925220
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Relationship between gene body DNA methylation and intragenic H3K9me3 and H3K36me3 chromatin marks.
    Hahn MA; Wu X; Li AX; Hahn T; Pfeifer GP
    PLoS One; 2011 Apr; 6(4):e18844. PubMed ID: 21526191
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.